Phio Pharmaceuticals Corp.
PHIO
$1.09
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 10.35% | 89.10% | |||
| Gross Profit | -10.35% | -89.10% | |||
| SG&A Expenses | -13.68% | 29.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.42% | 64.44% | |||
| Operating Income | -2.42% | -64.44% | |||
| Income Before Tax | -3.37% | -68.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.37% | -68.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.37% | -68.83% | |||
| EBIT | -2.42% | -64.44% | |||
| EBITDA | -2.42% | -64.47% | |||
| EPS Basic | -3.37% | -36.04% | |||
| Normalized Basic EPS | -3.34% | -36.07% | |||
| EPS Diluted | -3.37% | -36.04% | |||
| Normalized Diluted EPS | -3.34% | -36.07% | |||
| Average Basic Shares Outstanding | 0.00% | 24.13% | |||
| Average Diluted Shares Outstanding | 0.00% | 24.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||